{"entity":{"type":"insider","cik":"0002053936","url":"/insider/0002053936","json_url":"/insider/0002053936.json","name":"Martini Gregory S.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":3,"first":"2025-02-12","last":"2026-02-25","span_basis":"filed_date"},"name_variants":[{"name":"Martini Gregory S.","source":"filing","n_filings":3,"first_seen":"2025-02-12","last_seen":"2026-02-25"}],"transactions":[{"id":6171368,"accession":"0001193125-26-071515","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-071515","line_url":"/filing/0001193125-26-071515#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0002053936","owner_name":"Martini Gregory S.","owner_url":"/insider/0002053936","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11457.0,"shares_display":"11,457","price_per_share":3.66,"price_display":"3.66","price_state":"stated","total_value":41932.62,"total_display":"41,932.62","shares_owned_after":160601.0,"shares_owned_after_display":"160,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-25","scope":"insider"},{"id":6171364,"accession":"0001193125-26-071515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-071515","line_url":"/filing/0001193125-26-071515#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0002053936","owner_name":"Martini Gregory S.","owner_url":"/insider/0002053936","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10487.0,"shares_display":"10,487","price_per_share":3.81,"price_display":"3.81","price_state":"stated","total_value":39955.47,"total_display":"39,955.47","shares_owned_after":172058.0,"shares_owned_after_display":"172,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":4166045,"accession":"0000950170-25-108010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-108010","line_url":"/filing/0000950170-25-108010#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0002053936","owner_name":"Martini Gregory S.","owner_url":"/insider/0002053936","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1265.0,"shares_display":"1,265","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":1062.6,"total_display":"1,062.60","shares_owned_after":182545.0,"shares_owned_after_display":"182,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-13","scope":"insider"},{"id":4027253,"accession":"0000950170-25-019233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-019233","line_url":"/filing/0000950170-25-019233#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0002053936","owner_name":"Martini Gregory S.","owner_url":"/insider/0002053936","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12052.0,"shares_display":"12,052","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":21211.52,"total_display":"21,211.52","shares_owned_after":183810.0,"shares_owned_after_display":"183,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2025-02-12","last_seen":"2026-02-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002053936","retrieved_at":"2026-08-21T14:24:53+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}